Joseph Stringer

Stock Analyst at Needham

(0)
# 4147
Out of 5,270 analysts
306
Total ratings
28.97%
Success rate
-7.55%
Average return
23 Stocks
Name Action Price Target Current % Upside Ratings Updated
Lexicon Pharmaceutic...
Reiterates: Hold
n/a
n/a n/a 12 Mar 3, 2025
Vir Biotechnology
Reiterates: Buy
19 19
7.89 140.81% 16 Feb 27, 2025
Rhythm Pharmaceutica...
Reiterates: Buy
64 64
52.36 22.23% 21 Feb 27, 2025
Vaxcyte
Reiterates: Buy
140 140
72.02 94.39% 15 Feb 26, 2025
Alnylam Pharmaceutic...
Reiterates: Buy
320 320
243.64 31.34% 19 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
32.54 84.39% 18 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
22 22
7.38 198.1% 20 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
1.4 614.29% 16 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 4 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 5 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
28 28
5.21 437.43% 47 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
16 16
2.39 569.46% 17 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
29.2 105.48% 15 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 8 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
85 60
24.12 148.76% 19 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
23 23
1.09 2010.09% 16 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
23.21 7.71% 8 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 16 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
37
18.14 103.97% 5 Jan 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 5 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 32
n/a n/a 1 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 18
9.15 96.72% 2 Aug 24, 2021